Research & Innovation

February 12, 2026

MSN UK highlighted University of Cincinnati Cancer Center researchers studying the use of a delayed release preparation or wafer of an immunostimulatory molecule known as IL-15 to stimulate the central nervous system immune system after surgery to remove glioblastoma brain tumors.

February 12, 2026

The University of Cincinnati reached $346 million in sponsored research awards in fiscal year 2025, up 6.6% increase over the previous year. Additionally, funding for clinical trials at UC climbed, with $88 million in industry-sponsored awards and $33 million in federally sponsored awards.

February 9, 2026

UC Digital Technology Solutions (DTS) has released its January 2026 semiannual report, highlighting progress across the university’s digital transformation efforts and the many ways DTS is supporting innovation, operational excellence, and security across campus.